Curis
CRIS
#10227
Rank
โ‚น1.38 B
Marketcap
โ‚น107.25
Share price
-0.84%
Change (1 day)
-63.66%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น333.57. In 2024 the company made an earnings per share (EPS) of -โ‚น638.96 an increase over its 2023 EPS that were of -โ‚น820.74.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-50.56%
2024-โ‚น638.96-22.15%
2023-โ‚น820.74-26.17%
2022-โ‚น1,11222.3%
2021-โ‚น908.90-25.37%
2020-โ‚น1,218-30.93%
2019-โ‚น1,763-2.02%
2018-โ‚น1,800
2016-โ‚น4,090-10%
2015-โ‚น4,544138.1%
2014-โ‚น1,90940%
2013-โ‚น1,363-25%
2012-โ‚น1,81866.67%
2011-โ‚น1,091

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
โ‚น216.32-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น128.15-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.72-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น307.21-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น156.33-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น269.94-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,022 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA